The government has authorized the sale of self-test kits that allow individuals to collect their own samples and check for COVID-19 infection. The Ministry of Food and Drug Safety conditionally ...
Sugentech, Inc. engages in the development, manufacture, and commercializing technologies and products in the areas of multiplex immunoblot, point-of-care test, and digital healthcare based on BIO, ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Avellino is pleased to announce a strategic partnership with Sugentech (a Daejeon, Korea-based diagnostics company) to scale up the supply of tests designed to ...
Sugentech Inc. OverviewMedical Devices / Healthcare Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in ...
Ever since the 1980s, when the now-infamous "Turtle Traders" beat the market with simple strategies based on breakouts to new high prices, momentum investing has been shown to be a very profitable ...
South Korean biopharmaceutical firm Sugentech Inc. said Tuesday it has signed an agreement to export three different types of diagnostic kits for the novel coronavirus and seasonal influenza to the ...
Why does that matter? Relative strength is a useful tool for technical traders and investors, providing an instant measure of how a stock has performed in comparison with a benchmark. Studies by ...
CITY OF INDUSTRY, Calif., Sept. 13, 2018 /PRNewswire-PRWeb/ -- Sugentech, the maker of Surearly Digital Ovulation and Pregnancy Tests, has announced a promotion on its product line until the end of ...
View SugenTech (KQ:253840) annual reports, including income, balance sheet cash flow, and other data.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results